Levosulpiride 75mg + Rabeprazole 20mg capsule is a combination gastrointestinal therapy formulated for the effective management of acid-related disorders associated with impaired gastric motility, ensuring comprehensive symptom control.
Rabeprazole works by suppressing gastric acid secretion at the proton pump level, while levosulpiride enhances upper gastrointestinal motility and regulates dopamine receptors, helping relieve acidity, heartburn, bloating, nausea, and early satiety.
This capsule is commonly prescribed for gastroesophageal reflux disease (GERD), functional dyspepsia, chronic gastritis, acid peptic disorders, and reflux-associated gastrointestinal discomfort.
With dual-action efficacy, strong prescription acceptance, and suitability for both acute and long-term digestive care, this formulation supports consistent therapeutic demand and strengthens a comprehensive gastrointestinal product portfolio.